
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145835810.1021/acsomega.8b02740ArticleTransition Metal- and Oxidant-Free Base-Mediated Selenation
of Bicyclic Arenes at Room Temperature Ghosh Tubai Mukherjee Nilanjana Ranu Brindaban C. *Department of Organic Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India* E-mail: ocbcr@iacs.res.in (B.C.R.).17 12 2018 31 12 2018 3 12 17540 17546 10 10 2018 04 12 2018 Copyright © 2018 American Chemical Society2018American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

Bicyclic arenyl selenides
are of much importance because of their
pharmaceutical applications. A simple method for their synthesis has
been developed by a reaction of 2-naphthol and styrenyl selenocyanate/diaryl
diselenide in the presence of a base at room temperature. The selenation
occurs exclusively at the 1-position of 2-naphthol unit. The reactions
are relatively fast (2–4 h) and high yielding. A library of
substituted naphthyl styrenyl and naphthyl aryl selenides are obtained
by this procedure.

document-id-old-9ao8b02740document-id-new-14ao-2018-02740sccc-price
==== Body
1 Introduction
Organoselenium
compounds are of continued interest as the selenides
are found to possess useful activities such as agrochemicals, insecticides,
and drugs.1 They are often used as catalysts
and useful intermediates in organic reactions.2 They also have important applications as functional materials.3 The bicyclic arenyl selenides are of recent attention
as these compounds are found as lead drug candidates displaying a
broad range of bioactivities4 (Figure 1).

Figure 1 Examples of biologically
active bicyclic arenyl aryl organoselenides.

Thus, the development of a convenient method for the synthesis
of organoselenides is of high interest and the procedures are undergoing
continuous improvement. The widely accepted and practiced protocol
is the transition metal-catalyzed C–Se bond formation by the
coupling of aryl halides/boronic acids/triflates and selenol/PhSeNa/diphenyl
diselenide.5 However, these reactions usually
occur at a higher temperature for a relatively long reaction time.
Moreover, the coupling reaction requires prefunctionalization of the
aryl moiety. Recently, a direct selenation of C–H bond of benzamide
derivatives with diaryl diselenides in the presence of Pd catalyst
via C–H activation has been reported.6 The key factor in this type of C–H functionalization via
C–H activation is the presence of an appropriate directing
group. However, a general limitation of this method is the introduction
of a directing group prior to functionalization and difficulty in
removing this group after the reaction. Thus, we sought to find a
protocol for selenation of a C–H bond in a bicyclic arene unit
under transition metal-, oxidant-, and ligand-free condition avoiding
prefunctionalization as well as introduction of a neighboring directing
group. As a part of our continued program on selenation reaction,7 we report here selenation of 2-naphthols at the
1-position through C–H bond functionalization using Cs2CO3 in dimethyl sulfoxide (DMSO) at room temperature
(Scheme 1). When a
styrenyl selenocyanate is used as a selenating agent the corresponding
naphthyl styrenyl selenide is obtained, whereas the use of diaryl
diselenide provides the naphthyl aryl selenide.

Scheme 1 Base-Mediated C–H
Bond Selenation
Recently, Braga and
his co-workers reported a similar selenation
of 2-naphthols using diaryl diselenides in the presence of an oxidant
I2 and DMSO as a solvent under microwave irradiation or
oil bath heating.8 However, this method
did not address any vinyl selenation.

2 Results
and Discussion
To standardize the reaction conditions, a
series of experiments
were performed with variation of reaction parameters such as base,
solvent, and time for a representative reaction of naphthalen-2-ol
and (E)-(2-selenocyanatovinyl)benzene (Table 1). Initially, when the reaction
was performed using 2.0 equiv of K2CO3 as a
base in DMSO for 3 h, 51% of the desired product was formed (Table 1, entry 1). The change
of base to NaHCO3 produced only 35% of the corresponding
diaryl selenides (Table 1, entry 2). Interestingly, the use of Cs2CO3 increased the yield to 93% (Table 1, entry 3). In the absence of base, the reaction did
not initiate (Table 1, entry 5), which indicates the obvious requirement of base. On solvent
screening, N,N-dimethyl formamide
(DMF) and dichloroethane (DCE) did not show better results compared
to DMSO (Table 1, entries
6 and 7). The reaction did not progress in nonpolar solvents such
as toluene (Table 1, entry 8). The protic solvent, MeOH, provided 27% of the product
(Table 1, entry 9). N-Methyl pyrrolidinone (NMP) showed considerably good yield
(Table 1, entry 10).

Table 1 Optimization of Reaction Conditionsa,b
entry	base	solvent	yield (%)	
1	K2CO3	DMSO	51	
2	NaHCO3	DMSO	35	
3	Cs2CO3	DMSO	93	
4	NaOPiv	DMSO	12	
5	 	DMSO	 	
6	Cs2CO3	DMF	52	
7	Cs2CO3	DCE	25	
8	Cs2CO3	toluene	 	
9	Cs2CO3	MeOH	27	
10	Cs2CO3	NMP	57	
11c	Cs2CO3	DMSO	69	
12d	Cs2CO3	DMSO	94	
a Reaction conditions: a mixture of
naphthalen-2-ol (1a, 0.1 mmol), (E)-(2-selenocyanatovinyl)benzene
(1b, 0.1 mmol), and base (0.2 mmol) in dry solvent (2
mL) was stirred at room temperature under an argon atmosphere for
3 h.

b Isolated yield.

c For 2 h.

d For 4 h.

The yield of the product was reduced continuing a reaction for
2 h (Table 1, entry
11), and for 4 h the yield of product remained the same as in 3 h
(Table 1, entry 12).
Thus, in a general experimental procedure, a mixture of naphthalen-2-ol
(0.1 mmol), (E)-(2-selenocyanatovinyl)benzene (0.1
mmol), and Cs2CO3 (0.2 mmol) in DMSO (2 mL)
was stirred at room temperature for a certain period of time [thin
layer chromatography (TLC)] under an argon atmosphere. After evaporation
of DMSO, standard workup by extraction with ethyl acetate followed
by column chromatography over silica gel provided the pure product.

To test the generality of this reaction, a variety of styrenyl
selenocyanates were subjected to reaction with diversely substituted
2-naphthols by this procedure. The results are summarized in Scheme 2. A broad range of
electron-rich and electron-poor styrenyl selenocyanates underwent
reaction with 2-naphthol to produce the corresponding 1-naphthyl styrenyl
selenides in good-to-excellent yields. The reaction is uniform for
both electron-deficient and electron-rich substituted styrenyl selenocyanates.
Several functional groups such as trifluoromethoxy, methoxy, ethoxy,
fluoro, chloro, and bromo groups present at different positions of
styrenyl selenocyanates remained unaffected under the reaction conditions
(5, 6, 7, 8, 9, 10, 11, 12, 14, and 15), providing scope for the further
derivatization of the products. Various substituted 2-naphthols underwent
successful coupling with styrenyl selenocyanate to produce the corresponding
1-selenylated products in excellent yields (14 and 15). The reaction with heterocyclic hydroxy-arene, 6-hydroxy
quinoline, led to the corresponding selenylated product (12) in 88% yield.

Scheme 2 Selenation with Styrenyl Selenocyanates,
Reaction conditions: a mixture
of 1a (0.1 mmol), 1b (0.1 mmol), and Cs2CO3 (0.2 mmol) in DMSO (2 mL) was stirred at room
temperature under an argon atmosphere for 3 h.

Isolated yield.

For 2 h.

For 4 h.

Besides styrenyl selenocyanate, a range of electron-donating
and
electron-withdrawing diaryl diselenides also participated in this
reaction with 2-naphthol as Se-source to provide the corresponding
1-selenylated product under the same reaction conditions (Scheme 3). A 2-Naphthol unit
containing both electron-donating and electron-withdrawing groups
underwent successful coupling with diaryl diselenides to furnish the
corresponding naphthyl aryl selenides in good-to-excellent yields
(28, 29, 30, and 31). The reaction with the heterocyclic diselenide (thiophene) produced
the corresponding product (26) without any difficulty.

Scheme 3 Selenation with Diaryl Diselenides,
Reaction conditions: a mixture
of 1a (0.1 mmol), 1c (0.05 mmol), and Cs2CO3 (0.1 mmol) in DMSO (2 mL) was stirred at room
temperature under an argon atmosphere for 3 h.

Isolated yield.

For 2 h.

For 4 h.

We also performed the reaction on a gram scale, and
the product 1 was isolated in 80% yield (Scheme 4), which demonstrates the scalability
of
this C–H selenylation reaction.

Scheme 4 Gram-Scale Experiment
To find a possible reaction
pathway (ionic/radical), the reaction
was performed in the presence of a radical scavenger, 2,2,6,6-tetramethyl-1-piperidinyloxy
(Scheme 5). No change
in the reaction time and yield of product was observed. Thus, the
involvement of any radical intermediate was ruled out.

Scheme 5 Radical
Quenching Experiment
In accordance with our observation in Scheme 5 and the mechanism for a similar
reaction,8 we propose a reaction pathway
as outlined in Scheme 6. Initially, the
base Cs2CO3 interacts with 2-naphthol (1a) to form naphtholate anion A, which then reacts
with styrenyl selenocyanate (1b) at the 1-position to
form the species B. The intermediate B then
undergoes aromatization via proton elimination to form the product 1.

Scheme 6 Proposed Mechanistic Pathway
3 Conclusions
We have developed a general
and efficient method for the synthesis
of bicyclic arenyl styrenyl/aryl selenides by a simple reaction of
2-naphthol and styrenyl selenocyanate/diaryl diselenide in the presence
of a base at room temperature avoiding any oxidant, metal catalyst,
and additive which are usually involved in reported procedures for
the synthesis of selenides.5−8 To the best of our knowledge, this is the first report
for the synthesis of naphthyl styrenyl selenides, which may be of
potential for pharmaceutical applications. The attractive features
of this methodology are high yield of product, reaction at room temperature,
general applicability, and use of no metal and oxidant. We believe
that this procedure will find useful applications as a better alternative
for the synthesis of bicyclic arenyl styrenyl/aryl selenides. This
protocol may be of potential in organic synthesis as well as in pharmaceutical
industries.

4 Experimental Section
4.1 General
Information
Unless otherwise
stated, all reagents and solvents were purchased from commercial suppliers
and used without further purification. All reactions were performed
in oven-dried screw cap tube (10 mL) with a Teflon-coated magnetic
stirring bar at room temperature. Reactions were monitored by TLC
on silica gel 60 F254 and visualization was accomplished
by irradiation with UV light at 254 nm or vanillin staining solution
followed by heating. The crude product was purified by column chromatography
on Merck silica gel (100–200 mesh). All 1H and 13C NMR spectra were recorded on Bruker Avance III 500, 400,
and 300 MHz spectrometers in deuterated solvents (CDCl3). Proton chemical shifts are reported in ppm (δ) relative
to tetramethylsilane (TMS) with the solvent resonance employed as
the internal standard (CDCl3 δ 7.26 ppm). NMR data
are reported as follows: chemical shift, multiplicity (s = singlet,
d = doublet, t = triplet, q = quartet, m = multiplet, br = broad,
dd = double doublet, ddd = doublet of doublet of doublets), coupling
constants (Hz), and integration. 13C chemical shifts are
reported in ppm (δ) from TMS with the solvent resonance as the
internal standard (CDCl3 δ 77.16 ppm). Elemental
analyses were done in our institute with a PerkinElmer series II CHNS/O
autoanalyzer. IR spectra were recorded on a PerkinElmer Spectrum 100
FT-IR infrared spectrophotometer as neat for liquid compounds and
represented as IR (neat). The wave numbers (n) are
reported in cm–1.

4.2 Experimental
Procedures
Styrenyl
selenocyanates were prepared according to the literature procedure
from styrenyl bromide and KSeCN.9a Diaryl
diselenides were prepared following a literature procedure9b from aryl halide and selenium powder.

4.3 Representative Experimental Procedure for
the Reaction of Naphthalen-2-ol and (E)-(2-Selenocyanatovinyl)benzene
to (E)-1-(Styrenylselanyl)naphthalen-2-ol (Scheme 2, 1)
A dry screw cap tube (10 mL) equipped with a magnetic stirring
bar was charged with naphthalen-2-ol (14 mg, 0.1 mmol), (E)-(2-selenocyanatovinyl)benzene (21 mg, 0.1 mmol), Cs2CO3 (65 mg, 0.2 mmol, 2 equiv), and DMSO (2 mL). Then,
the reaction mixture was stirred at room temperature under an argon
atmosphere. After completion of the reaction (TLC), the mixture was
extracted with EtOAc (3 × 20 mL). The organic phase was dried
(Na2SO4) and evaporated to leave the crude product,
which was purified by silica gel column chromatography (hexane–EtOAc,
98:2) to provide the pure (E)-1-(styrenylselanyl)naphthalen-2-ol
(1) as a pale orange liquid (30 mg, 93%).

4.3.1 (E)-1-(Styrenylselanyl)naphthalen-2-ol
(1)
Pale orange liquid (30 mg, 93%). 1H NMR (400 MHz, chloroform-d): δ 8.33 (d, J = 8.5 Hz, 1H), 7.91 (d, J = 8.9 Hz, 1H),
7.84 (d, J = 8.1 Hz, 1H), 7.58 (ddd, J = 8.4, 6.7, 1.3 Hz, 1H), 7.45–7.36 (m, 2H), 7.30–7.23
(m, 2H), 7.23–7.17 (m, 3H), 6.98 (s, 1H), 6.85 (d, J = 15.7 Hz, 1H), 6.56 (d, J = 15.7 Hz,
1H). 13C NMR (75 MHz, CDCl3): δ 156.00,
136.65, 135.75, 133.50, 132.67, 129.54, 128.67, 128.61, 127.97, 127.68,
126.95, 126.05, 123.87, 117.60, 116.71, 108.02. IR (cm–1): 3389, 3056, 1618, 1594, 1459, 1383. Anal. Calcd for C18H14OSe: C, 66.47; H, 4.34. Found: C, 66.41; H, 4.40.

4.3.2 (E)-1-((4-Methylstyrenyl)selanyl)naphthalen-2-ol
(2)
Pale yellow liquid (31 mg, 91%). 1H NMR (300 MHz, chloroform-d): δ 8.30 (d, J = 9.7 Hz, 1H), 7.84 (dd, J = 20.7, 8.6
Hz, 2H), 7.53 (d, J = 7.7 Hz, 1H), 7.48–7.28
(m, 2H), 7.15–6.98 (m, 4H), 6.95 (s, 1H), 6.82–6.66
(m, 1H), 6.53 (d, J = 15.7 Hz, 1H), 2.27 (d, J = 4.3 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 155.98, 137.64, 135.78, 133.97, 133.72, 132.60, 129.55,
129.38, 128.60, 128.43, 127.94, 127.84, 127.02, 126.00, 123.85, 116.70,
116.26, 108.23, 21.30. IR (cm–1): 3360, 3052, 1591,
1447, 1421, 1228, 930, 816. Anal. Calcd for C19H16OSe: C, 67.26; H, 4.75. Found: C, 67.33; H, 4.83.

4.3.3 (E)-1-((4-Ethylstyrenyl)selanyl)naphthalen-2-ol
(3)
Pale orange liquid (33 mg, 93%). 1H NMR (400 MHz, chloroform-d): δ 8.20 (d, J = 8.6 Hz, 1H), 7.78 (d, J = 9.0 Hz, 1H),
7.71 (d, J = 8.2 Hz, 1H), 7.45 (ddd, J = 8.4, 6.8, 1.3 Hz, 1H), 7.33–7.20 (m, 2H), 6.99 (q, J = 8.2 Hz, 4H), 6.86 (s, 1H), 6.67 (d, J = 15.6 Hz, 1H), 6.45 (d, J = 15.7 Hz, 1H), 2.48
(q, J = 7.6 Hz, 2H), 1.09 (t, J =
7.6 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ
155.98, 144.07, 135.78, 134.22, 133.75, 132.60, 129.54, 128.60, 128.53,
128.20, 127.94, 127.01, 126.08, 123.85, 116.69, 116.32, 108.23, 28.70,
15.61. IR (cm–1): 3392, 3025, 2963, 1618, 1594,
1459. Anal. Calcd for C20H18OSe: C, 67.99; H,
5.14. Found: C, 68.08; H, 5.07.

4.3.4 (E)-1-((4-Isopropylstyrenyl)selanyl)naphthalen-2-ol
(4)
Reddish gummy liquid (32 mg, 89%). 1H NMR (300 MHz, chloroform-d): δ 8.28
(dd, J = 8.4, 1.1 Hz, 1H), 7.87 (d, J = 8.9 Hz, 1H), 7.80 (dd, J = 8.0, 1.4 Hz, 1H),
7.53 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H), 7.43–7.28
(m, 3H), 7.10 (s, 3H), 6.94 (s, 1H), 6.76 (d, J =
15.6 Hz, 1H), 6.54 (d, J = 15.7 Hz, 1H), 2.83 (dt, J = 13.8, 6.9 Hz, 1H), 1.19 (d, J = 6.9
Hz, 6H). 13C NMR (126 MHz, CDCl3): δ 156.06,
148.77, 135.87, 134.47, 134.00, 132.59, 129.64, 128.62, 127.94, 127.05,
126.79, 126.15, 123.86, 116.74, 116.37, 108.37, 34.00, 23.97. IR (cm–1): 3357, 3058, 2934, 1612, 1587, 1138, 995. Anal.
Calcd for C21H20OSe: C, 68.66; H, 5.49. Found:
C, 68.78; H, 5.58.

4.3.5 (E)-1-((4-(Trifluoromethoxy)styrenyl)selanyl)naphthalen-2-ol
(5)
Reddish gummy liquid (37 mg, 90%). 1H NMR (400 MHz, chloroform-d): δ 8.28–8.23
(m, 1H), 7.89 (d, J = 8.9 Hz, 1H), 7.82 (dd, J = 8.1, 1.3 Hz, 1H), 7.55 (ddd, J = 8.4,
6.9, 1.3 Hz, 1H), 7.39 (ddd, J = 8.1, 6.9, 1.2 Hz,
1H), 7.35 (d, J = 8.9 Hz, 1H), 7.19–7.13 (m,
2H), 7.07 (d, J = 8.4 Hz, 2H), 6.89 (s, 1H), 6.82
(d, J = 15.7 Hz, 1H), 6.44 (d, J = 15.6 Hz, 1H). 13C NMR (101 MHz, CDCl3):
δ 156.10, 148.56, 135.57 (q, 2JC–F = 31.0 Hz), 132.87,
131.77, 129.86, 129.63, 128.70, 128.13, 128.08, 127.79, 127.30, 126.86,
123.99, 121.30, 121.20, 120.54 (q, 1JC–F = 255.0 Hz), 119.15,
118.98, 116.78, 107.73. IR (cm–1): 3393, 3061, 1595,
1505, 1256. Anal. Calcd for C19H13F3O2Se: C, 55.76; H, 3.20. Found: C, 55.68; H, 3.25.

4.3.6 (E)-1-((3-Methoxy-4-(pentyloxy)styrenyl)selanyl)naphthalen-2-ol
(6)
Orange liquid (38 mg, 87%). 1H NMR (400 MHz, chloroform-d): δ 8.22 (d, J = 8.4 Hz, 1H), 7.74 (dd, J = 25.9, 8.7
Hz, 2H), 7.45 (ddd, J = 8.3, 6.8, 1.3 Hz, 1H), 7.33–7.21
(m, 2H), 6.89 (s, 1H), 6.62 (dd, J = 4.3, 1.9 Hz,
3H), 6.55 (d, J = 15.6 Hz, 1H), 6.44 (d, J = 15.6 Hz, 1H), 3.86 (t, J = 6.9 Hz,
2H), 3.70 (s, 3H), 1.72 (d, J = 14.4 Hz, 2H), 1.38–1.21
(m, 4H), 0.82 (t, J = 7.0 Hz, 3H). 13C
NMR (101 MHz, CDCl3): δ 156.00, 149.60, 148.69, 135.83,
133.93, 132.54, 129.83, 129.54, 128.58, 127.91, 127.04, 123.83, 119.41,
116.70, 114.79, 112.88, 109.16, 108.42, 69.19, 56.11, 28.95, 28.19,
22.57, 14.10. IR (cm–1): 3408, 3055, 2954, 2928,
1509, 1595, 1262. Anal. Calcd for C24H26O3Se: C, 65.30; H, 5.94. Found: C, 65.36; H, 5.99.

4.3.7 (E)-1-((4-Ethoxy-3,5-dimethoxystyrenyl)selanyl)naphthalen-2-ol
(7)
Yellowish gummy liquid (36 mg, 85%). 1H NMR (300 MHz, chloroform-d): δ 8.33–8.25
(m, 1H), 7.88 (d, J = 8.9 Hz, 1H), 7.85–7.78
(m, 1H), 7.55 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.44–7.32
(m, 2H), 6.94 (s, 1H), 6.72 (d, J = 15.5 Hz, 1H),
6.47 (d, J = 15.6 Hz, 1H), 6.39 (s, 2H), 4.00 (q, J = 7.1 Hz, 2H), 3.78 (s, 6H), 1.31 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ
156.05, 153.73, 136.99, 135.82, 133.65, 132.70, 132.26, 129.55, 128.62,
128.01, 127.01, 123.92, 116.75, 116.67, 108.06, 103.30, 69.06, 56.25,
15.59. IR (cm–1): 3387, 3064, 1616, 1518, 1362.
Anal. Calcd for C22H22O4Se: C, 61.54;
H, 5.16. Found: C, 61.59; H, 5.29.

4.3.8 (E)-1-((4-Allyl-3-methoxystyrenyl)selanyl)naphthalen-2-ol
(8)
Orange liquid (35 mg, 88%). 1H NMR (300 MHz, chloroform-d): δ 8.31 (d, J = 8.5 Hz, 1H), 7.87 (d, J = 8.8 Hz, 1H),
7.81 (dd, J = 8.1, 1.3 Hz, 1H), 7.55 (ddd, J = 8.3, 6.8, 1.4 Hz, 1H), 7.42–7.37 (m, 1H), 7.34
(d, J = 8.9 Hz, 1H), 6.98 (s, 1H), 6.78–6.70
(m, 3H), 6.70–6.61 (m, 1H), 6.52 (d, J = 15.6
Hz, 1H), 6.04 (ddt, J = 17.3, 10.7, 5.4 Hz, 1H),
5.36 (dq, J = 17.3, 1.6 Hz, 1H), 5.30–5.22
(m, 1H), 4.66–4.57 (m, 1H), 4.00–3.86 (m, 1H), 3.80
(s, 3H). 13C NMR (75 MHz, CDCl3): δ 155.96,
149.54, 147.92, 135.79, 133.70, 133.21, 132.58, 130.19, 129.51, 128.59,
127.93, 127.02, 123.84, 119.23, 118.20, 116.69, 115.11, 113.29, 108.93,
108.31, 69.92, 56.01. IR (cm–1): 3389, 2934, 1594,
1508, 1460. Anal. Calcd for C22H20O2Se: C, 66.84; H, 5.10. Found: C, 66.96; H, 5.19.

4.3.9 (E)-1-((4-Fluorostyrenyl)selanyl)naphthalen-2-ol
(9)
Orange gummy liquid (31 mg, 92%). 1H NMR (300 MHz, chloroform-d): δ 8.29 (d, J = 8.5 Hz, 1H), 7.89 (d, J = 8.9 Hz, 1H),
7.82 (d, J = 8.1 Hz, 1H), 7.56 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H), 7.45–7.32 (m, 2H), 7.17–7.07
(m, 2H), 6.98–6.87 (m, 3H), 6.73 (d, J = 15.6
Hz, 1H), 6.47 (d, J = 15.7 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 162.31 (d, 1JC–F = 246.0 Hz), 156.01, 135.73, 132.96, 132.92, 132.73, 132.30,
129.56, 128.65, 128.01, 127.65, 127.55, 126.90, 123.91, 117.21, 117.17,
116.72, 115.60 (d, 2JC–F = 21.75 Hz), 107.95. IR (cm–1): 3404, 3087, 2954, 1592, 1511, 1478. Anal. Calcd
for C18H13FOSe: C, 62.98; H, 3.82. Found: C,
63.04; H, 3.84.

4.3.10 (E)-1-((4-Bromostyrenyl)selanyl)naphthalen-2-ol
(10)
Yellowish liquid (35 mg, 88%). 1H NMR (400 MHz, chloroform-d): δ 8.25 (d, J = 8.5 Hz, 1H), 7.89 (d, J = 8.9 Hz, 1H),
7.81 (dd, J = 8.1, 1.2 Hz, 1H), 7.55 (ddd, J = 8.3, 6.8, 1.3 Hz, 1H), 7.39 (ddd, J = 8.2, 6.8, 1.2 Hz, 1H), 7.35 (d, J = 3.5 Hz, 1H),
7.33 (d, J = 3.1 Hz, 2H), 7.04–6.99 (m, 2H),
6.88 (s, 1H), 6.83 (d, J = 15.7 Hz, 1H), 6.40 (d, J = 15.7 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 156.07, 135.73, 135.63, 132.84, 132.05, 131.96,
131.80, 129.61, 128.68, 128.07, 127.54, 126.87, 123.97, 121.47, 118.77,
116.77, 107.74. IR (cm–1): 3382, 2964, 1618, 1383,
1268. Anal. Calcd for C18H13BrOSe: C, 53.49;
H, 3.24. Found: C, 53.55; H, 3.18.

4.3.11 (E)-1-((2,4-Dichlorostyrenyl)selanyl)naphthalen-2-ol
(11)
Yellowish liquid (35 mg, 91%). 1H NMR (300 MHz, chloroform-d): δ 8.29 (dq, J = 8.5, 0.9 Hz, 1H), 7.92 (d, J = 8.9
Hz, 1H), 7.89–7.80 (m, 1H), 7.59 (ddd, J =
8.4, 6.9, 1.3 Hz, 1H), 7.48–7.35 (m, 2H), 7.30 (q, J = 2.5 Hz, 2H), 7.14 (d, J = 2.0 Hz, 1H),
7.12 (d, J = 3.0 Hz, 1H), 6.87 (s, 2H). 13C NMR (101 MHz, CDCl3): δ 156.07, 135.66, 133.65,
133.44, 132.95, 129.61, 128.71, 128.47, 128.11, 127.43, 127.32, 126.82,
122.07, 116.79, 107.76. IR (cm–1): 3394, 3068, 1595,
1508, 1207. Anal. Calcd for C18H12Cl2OSe: C, 54.85; H, 3.07. Found: C, 54.93; H, 3.02.

4.3.12 (E)-5-((4-Fluorostyrenyl)selanyl)quinolin-6-ol
(12)
Pale yellow oil (30 mg, 88%). 1H NMR (300 MHz, chloroform-d): δ 8.79 (dd, J = 4.2, 1.6 Hz, 1H), 8.58 (ddd, J = 8.5,
1.6, 0.8 Hz, 1H), 8.15 (dd, J = 9.2, 0.8 Hz, 1H),
7.58 (d, J = 9.2 Hz, 1H), 7.45 (dd, J = 8.5, 4.2 Hz, 1H), 7.36–7.27 (m, 1H), 7.23–7.08 (m,
2H), 6.92 (t, J = 8.7 Hz, 2H), 6.70 (dd, J = 15.7, 0.5 Hz, 1H), 6.43 (d, J = 15.7
Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 162.52
(d, 1JC–F = 247.0 Hz), 156.40, 148.10, 144.89, 136.01, 135.22, 134.11,
132.93, 132.76, 132.72, 131.22, 128.17 (d, 3JC–F =
8.0 Hz), 127.72 (d, 3JC–F = 8.0 Hz), 122.68, 120.32,
116.54, 116.52, 115.87, 115.82 (d, 2JC–F = 22.0 Hz),115.65,
107.32. IR (cm–1): 3406, 3104, 1597, 1507, 1447.
Anal. Calcd for C17H12FNOSe: C, 59.31; H, 3.51;
N, 4.07. Found: C, 59.36; H, 3.58; N, 4.11.

4.3.13 (E)-1-((4-(Trifluoromethyl)styrenyl)selanyl)naphthalen-2-ol
(13)
Reddish liquid (35 mg, 89%). 1H NMR (400 MHz, chloroform-d): δ 8.24 (d, J = 8.5 Hz, 1H), 7.90 (d, J = 8.9 Hz, 1H),
7.82 (d, J = 8.0 Hz, 1H), 7.60–7.52 (m, 2H),
7.47 (d, J = 8.1 Hz, 2H), 7.43–7.37 (m, 1H),
7.35 (d, J = 8.8 Hz, 1H), 7.24 (d, J = 8.3 Hz, 2H), 6.98 (d, J = 15.7 Hz, 1H), 6.85
(s, 1H), 6.44 (d, J = 15.6 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 156.16, 145.39, 140.01,
135.92, 135.72, 134.65, 133.01, 131.52, 131.01, 129.78 (q, 2JC–F = 32 Hz), 129.66, 128.73,
128.15, 126.81, 126.62, 126.17, 125.75, 125.71, 125.67, 125.64, 124.05,
121.28, 116.83, 116.78 (q, 1JC–F = 249 Hz), 107.42, 100.15. IR (cm–1): 3395, 3062,
1596, 1463, 1207. Anal. Calcd for C19H13F3OSe: C, 58.03; H, 3.33. Found: C, 57.98; H, 3.39.

4.3.14 (E)-1-((3-Chlorostyrenyl)selanyl)-7-methoxynaphthalen-2-ol
(14)
Light red liquid (31 mg, 81%). 1H NMR (300 MHz, chloroform-d): δ 7.78 (d, J = 8.8 Hz, 1H), 7.70 (d, J = 8.8 Hz, 1H),
7.62 (d, J = 2.6 Hz, 1H), 7.23–7.15 (m, 2H),
7.07–7.00 (m, 2H), 6.96 (dd, J = 3.0, 1.3
Hz, 1H), 6.89 (s, 1H), 6.66 (d, J = 15.6 Hz, 1H),
6.58–6.49 (m, 1H), 3.92 (s, 3H). 13C NMR (75 MHz,
CDCl3): δ 159.60, 156.56, 139.19, 137.51, 132.37,
130.27, 128.05, 126.29, 124.72, 124.69, 121.84, 116.73, 116.05, 114.07,
107.14, 106.19, 55.52. IR (cm–1): 3381, 3057, 2936,
1618, 1511, 1577, 1463. Anal. Calcd for C19H15ClO2Se: C, 58.55; H, 3.88. Found: C, 58.60; H, 3.92.

4.3.15 (E)-6-Bromo-1-((4-methylstyrenyl)selanyl)naphthalen-2-ol
(15)
Orange liquid (36 mg, 87%). 1H NMR (300 MHz, chloroform-d): δ 8.07 (d, J = 9.0 Hz, 1H), 7.86 (t, J = 2.5 Hz, 1H),
7.68 (d, J = 8.8 Hz, 1H), 7.50 (dd, J = 9.0, 2.0 Hz, 1H), 7.26 (d, J = 9.0 Hz, 1H), 7.18
(s, 1H), 6.97 (d, J = 2.0 Hz, 3H), 6.87 (d, J = 5.2 Hz, 1H), 6.62 (d, J = 15.6 Hz,
1H), 6.41 (d, J = 15.7 Hz, 1H), 2.19 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 156.25, 137.85,
134.44, 134.11, 133.79, 131.58, 131.11, 130.55, 130.46, 129.46, 129.43,
128.98, 128.43, 126.03, 117.83, 117.71, 115.71, 108.45, 21.32. IR
(cm–1): 3391, 3352, 2964, 1566, 1509, 1469, 1349.
Anal. Calcd for C19H15BrOSe: C, 54.57; H, 3.62.
Found: C, 54.63; H, 3.64.

4.3.16 1-(m-Tolylselanyl)naphthalen-2-ol
(17)
Yellow liquid (27 mg, 87%). 1H NMR (300 MHz, chloroform-d): δ 8.32 (d, J = 8.5 Hz, 1H), 7.90 (d, J = 8.9 Hz, 1H),
7.82 (d, J = 8.1 Hz, 1H), 7.57–7.47 (m, 1H),
7.38 (dt, J = 7.8, 3.2 Hz, 2H), 7.17 (s, 1H), 7.10–7.00
(m, 2H), 6.95 (t, J = 7.3 Hz, 2H), 2.23 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 156.31, 139.41,
135.98, 132.81, 130.41, 129.85, 129.56, 129.37, 128.56, 127.97, 127.68,
127.10, 126.30, 123.83, 116.66, 109.26, 21.44. IR (cm–1): 3360, 3056, 1587, 1477, 1425. Anal. Calcd for C17H14OSe: C, 65.18; H, 4.50. Found: C, 65.22; H, 4.55.

4.3.17 1-((2,4-Dimethylphenyl)selanyl)naphthalen-2-ol
(18)
Yellow liquid (28 mg, 85%). 1H NMR (300 MHz, chloroform-d): δ 8.07 (d, J = 9.0 Hz, 1H), 7.96 (d, J = 2.1 Hz, 1H),
7.80 (d, J = 8.9 Hz, 1H), 7.52 (dd, J = 9.0, 2.1 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 7.07–6.97
(m, 2H), 6.74–6.60 (m, 1H), 6.42 (d, J = 8.0
Hz, 1H), 2.50 (s, 3H), 2.21 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 157.24, 137.28, 136.95, 135.16, 132.17, 131.94,
131.58, 131.04, 130.88, 129.48, 128.40, 128.37, 127.43, 118.27, 118.16,
109.00, 22.03, 21.29. IR (cm–1): 3382, 2922, 1586,
1495, 1473. Anal. Calcd for C18H16OSe: C, 66.06;
H, 4.93. Found: C, 66.01; H, 4.97.

4.3.18 1-((2-Fluorophenyl)selanyl)naphthalen-2-ol
(20)
Orange liquid (28 mg, 90%). 1H NMR (300 MHz, chloroform-d): δ 8.29 (dq, J = 8.5, 0.9 Hz, 1H), 7.92 (d, J = 8.9
Hz, 1H), 7.86–7.80 (m, 1H), 7.53 (ddd, J =
8.4, 6.9, 1.4 Hz, 1H), 7.44–7.36 (m, 2H), 7.17–7.06
(m, 3H), 6.82 (td, J = 7.5, 1.5 Hz, 1H), 6.72 (ddd, J = 7.9, 6.8, 1.7 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 160.78 (d, 1JC–F = 240.75 Hz), 156.80, 136.03, 133.20, 130.71, 130.67, 129.59, 128.65,
128.52 (d, 3JC–F = 7.5
Hz), 128.16, 126.82, 125.28, 125.23, 123.98, 117.30 (d, 2JC–F = 21.75 Hz), 116.79, 115.56
(d, 2JC–F = 21.75 Hz),
106.80, 106.77. IR (cm–1): 3365, 2924, 1598, 1447,
1324, 1251. Anal. Calcd for C16H11FOSe: C, 60.58;
H, 3.50. Found: C, 60.61; H, 3.52.

4.3.19 1-((4-(Trifluoromethoxy)phenyl)selanyl)naphthalen-2-ol
(21)
Reddish liquid (33 mg, 87%). 1H NMR (300 MHz, chloroform-d): δ 8.28–8.21
(m, 1H), 7.91 (d, J = 8.9 Hz, 1H), 7.85–7.79
(m, 1H), 7.52 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.43–7.37
(m, 1H), 7.36 (d, J = 4.3 Hz, 1H), 7.19–7.13
(m, 2H), 7.07–6.97 (m, 3H). 13C NMR (126 MHz, CDCl3): δ 156.43, 148.27, 135.75, 133.40, 133.18, 130.47,
129.67, 129.00, 128.85, 128.63, 128.38, 128.19, 126.79 (q, 2JC–F = 21.25 Hz), 124.16, 124.04,
122.27, 122.17, 120.48 (q, 1JC–F = 256.25 Hz), 116.85, 116.73, 108.77. IR (cm–1): 3371, 3052, 1594, 1454, 1373, 1199. Anal. Calcd for C17H11F3O2Se: C, 53.28; H, 2.89. Found:
C, 53.33; H, 2.97.

4.3.20 1-((3-Chlorophenyl)selanyl)naphthalen-2-ol
(22)
Yellow liquid (29 mg, 89%). 1H NMR (300 MHz, chloroform-d): δ 8.23 (dt, J = 8.5, 1.0 Hz, 1H), 7.92 (d, J = 8.9
Hz, 1H), 7.85–7.79 (m, 1H), 7.52 (ddd, J =
8.4, 6.9, 1.4 Hz, 1H), 7.43–7.35 (m, 2H), 7.16 (t, J = 1.8 Hz, 1H), 7.15–7.09 (m, 1H), 7.06 (d, J = 7.7 Hz, 1H), 7.03 (s, 1H), 6.98 (dt, J = 7.6, 1.5 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 156.47, 135.75, 135.37, 133.35, 132.43, 130.52, 129.63,
128.80, 128.71, 128.25, 127.13, 127.00, 126.78, 124.07, 116.77, 108.35.
IR (cm–1): 3368, 3047, 1577, 1586, 1467, 1368. Anal.
Calcd for C16H11ClOSe: C, 57.59; H, 3.32. Found:
C, 57.66; H, 3.28.

4.3.21 1-((3-Bromophenyl)selanyl)naphthalen-2-ol
(23)
Yellow liquid (32 mg, 87%). 1H NMR (500 MHz, chloroform-d): δ 8.17–8.11
(m, 1H), 7.82 (d, J = 8.9 Hz, 1H), 7.72 (dd, J = 8.2, 1.3 Hz, 1H), 7.42 (ddd, J = 8.4,
6.9, 1.4 Hz, 1H), 7.32–7.24 (m, 3H), 7.18 (dt, J = 7.6, 2.0 Hz, 1H), 6.92 (d, J = 2.4 Hz, 1H), 6.91–6.86
(m, 2H). 13C NMR (75 MHz, CDCl3): δ 156.44,
135.71, 133.34, 132.76, 131.57, 130.85, 129.87, 129.61, 128.70, 128.25,
127.55, 126.76, 124.07, 123.49, 116.77, 108.35. IR (cm–1): 3408, 3088, 2955, 1589, 1505, 1476. Anal. Calcd for C16H11BrOSe: C, 50.82; H, 2.93. Found: C, 50.88; H, 2.96.

4.3.22 1-(Naphthalen-2-ylselanyl)naphthalen-2-ol
(25)
Orange liquid (28 mg, 82%). 1H NMR (300 MHz, chloroform-d): δ 8.34 (d, J = 8.4 Hz, 1H), 8.28 (d, J = 8.4 Hz, 1H),
7.96 (d, J = 8.9 Hz, 1H), 7.86 (t, J = 7.5 Hz, 2H), 7.66 (d, J = 8.1 Hz, 2H), 7.57 (t, J = 7.5 Hz, 1H), 7.53–7.35 (m, 3H), 7.16–7.04
(m, 2H), 6.84 (d, J = 7.3 Hz, 1H). 13C
NMR (75 MHz, CDCl3): δ 156.83, 136.14, 134.22, 133.09,
132.56, 129.71, 129.29, 128.92, 128.64, 128.14, 127.06, 126.98, 126.76,
126.45, 126.38, 126.14, 125.32, 123.99, 116.84, 107.96. IR (cm–1): 3396, 3062, 1598, 1547, 1477, 1258. Anal. Calcd
for C20H14OSe: C, 68.77; H, 4.04. Found: C,
68.82; H, 4.09.

4.3.23 1-(Thiophen-2-ylselanyl)naphthalen-2-ol
(26)
Reddish gummy liquid (24 mg, 80%). 1H NMR (300 MHz, chloroform-d): δ 8.48
(dt, J = 8.5, 1.0 Hz, 1H), 7.82 (d, J = 8.9 Hz, 1H), 7.80–7.74 (m, 1H), 7.58 (ddd, J = 8.4, 6.9, 1.3 Hz, 1H), 7.37 (ddd, J = 8.1, 6.9,
1.2 Hz, 1H), 7.30 (d, J = 8.9 Hz, 1H), 7.23 (dd, J = 5.3, 1.2 Hz, 1H), 7.19 (dd, J = 3.6,
1.0 Hz, 2H), 6.87 (dd, J = 5.2, 3.6 Hz, 1H). 13C NMR (75 MHz, CDCl3): δ 155.57, 135.32,
133.40, 132.82, 129.78, 129.55, 128.66, 127.93, 126.88, 124.27, 123.86,
116.75, 111.85, 100.12. IR (cm–1): 3364, 3052, 1617,
1600, 1478, 1352, 1330. Anal. Calcd for C14H10OSSe: C, 55.09; H, 3.30. Found: C, 55.20; H, 3.39.

4.3.24 6-Bromo-1-(phenylselanyl)naphthalen-2-ol
(27)
Orange liquid (32 mg, 86%). 1H NMR (300 MHz, chloroform-d): δ 8.15 (d, J = 9.0 Hz, 1H), 7.94 (d, J = 2.0 Hz, 1H),
7.78 (d, J = 8.9 Hz, 1H), 7.54 (dd, J = 9.1, 2.1 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 7.15
(s, 6H). 13C NMR (75 MHz, CDCl3): δ 156.56,
134.52, 131.82, 131.16, 130.52, 130.43, 130.30, 129.64, 129.22, 128.97,
126.91, 117.80, 117.75, 109.38. IR (cm–1): 3404,
3056, 1598, 1577, 1478, 1068. Anal. Calcd for C16H11BrOSe: C, 50.82; H, 2.93. Found: C, 50.76; H, 2.91.

4.3.25 6-Bromo-1-((3-fluorophenyl)selanyl)naphthalen-2-ol
(28)
Yellowish liquid (34 mg, 88%). 1H NMR (300 MHz, chloroform-d): δ 8.09 (d, J = 9.0 Hz, 1H), 7.95 (d, J = 2.0 Hz, 1H),
7.80 (d, J = 8.9 Hz, 1H), 7.55 (dd, J = 9.0, 2.1 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 7.12
(td, J = 8.0, 5.8 Hz, 1H), 7.03 (s, 1H), 6.92 (dt, J = 7.8, 1.2 Hz, 1H), 6.86 (dt, J = 8.3,
1.7 Hz, 1H), 6.83–6.75 (m, 1H). 13C NMR (75 MHz,
CDCl3): δ 163.22 (d, 1JC–F = 249.0 Hz), 156.68, 134.37,
132.24, 132.15, 131.36, 130.88, 130.78, 130.59, 130.55, 130.01, 129.28,
128.72, 128.51, 124.66, 124.61, 122.42, 118.62, 117.93, 117.90, 116.06
(d, 2JC–F = 24 Hz), 114.0 (d, 2JC–F = 21 Hz), 108.61. IR (cm–1): 3410, 3102, 1594, 1510, 1468, 1207. Anal. Calcd for C16H10BrFOSe: C, 48.51; H, 2.54. Found: C, 48.57; H, 2.58.

4.3.26 6-Hydroxy-5-(phenylselanyl)-2-naphthaldehyde
(30)
Orange liquid (28 mg, 87%). 1H NMR (400 MHz, chloroform-d): δ 10.12 (s,
1H), 8.38 (d, J = 8.7 Hz, 1H), 8.29 (d, J = 1.7 Hz, 1H), 8.03 (d, J = 8.9 Hz, 1H), 7.96 (dd, J = 8.8, 1.7 Hz, 1H), 7.45 (d, J = 8.9
Hz, 1H), 7.40 (s, 1H), 7.16 (s, 5H). 13C NMR (75 MHz, CDCl3): δ 191.83, 158.89, 139.60, 134.52, 134.40, 132.39,
130.02, 129.73, 129.35, 128.70, 128.21, 127.11, 125.43, 117.98, 110.14.
IR (cm–1): 3361, 3064, 2928, 1689, 1615, 1596, 1577.
Anal. Calcd for C17H12O2Se: C, 62.40;
H, 3.70. Found: C, 62.44; H, 3.73.

4.3.27 Methyl
6-hydroxy-5-(phenylselanyl)-2-naphthoate
(31)
Light orange gummy liquid (30 mg, 84%). 1H NMR (300 MHz, chloroform-d): δ 8.53
(d, J = 1.8 Hz, 1H), 8.29 (d, J =
8.9 Hz, 1H), 8.05 (dd, J = 8.8, 1.8 Hz, 1H), 7.96
(d, J = 8.9 Hz, 1H), 7.40 (d, J =
8.9 Hz, 1H), 7.33 (s, 1H), 7.14 (s, 5H), 3.96 (s, 3H). 13C NMR (75 MHz, CDCl3): δ 167.12, 158.18, 138.45,
134.14, 131.57, 130.21, 129.60, 129.26, 128.53, 127.45, 127.26, 126.91,
125.50, 117.57, 109.51, 52.25. IR (cm–1): 3368,
3057, 2949, 1714, 1618, 1596, 1577, 1468. Anal. Calcd for C18H14O3Se: C, 60.51; H, 3.95. Found: C, 60.45;
H, 4.01.

4.3.28 5-(Phenylselanyl)quinolin-6-ol
(32)
Brownish gummy liquid (27 mg, 91%). 1H NMR
(300 MHz, chloroform-d): δ 8.76 (dd, J = 4.3, 1.6 Hz, 1H), 8.58 (ddd, J = 8.5,
1.7, 0.8 Hz, 1H), 8.15 (dd, J = 9.2, 0.8 Hz, 1H),
7.59 (d, J = 9.2 Hz, 1H), 7.39 (dd, J = 8.5, 4.2 Hz, 1H), 7.19–7.10 (m, 6H). 13C NMR
(75 MHz, CDCl3): δ 156.68, 148.00, 144.80, 135.38,
134.13, 131.36, 130.25, 129.72, 129.23, 127.01, 122.69, 120.33, 108.56.
IR (cm–1): 3382, 3056, 2844, 1608, 1577, 1495, 1476.
Anal. Calcd for C15H11NOSe: C, 60.01; H, 3.69;
N, 4.67. Found: C, 60.12; H, 3.76; N, 4.62.

Supporting Information Available
The Supporting Information is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b02740.Characterization
data of all known compounds and 1H and 13C NMR
spectra of all products (PDF)



Supplementary Material
ao8b02740_si_001.pdf

 The
authors declare no
competing financial interest.

Acknowledgments
Financial support from Indian National Science
Academy,
New Delhi, under the offer of INSA Senior Scientist position to B.C.R.
is gratefully acknowledged.
==== Refs
References
a Mugesh G. ; du Mont W.-W. ; Sies H. 
Chemistry of Biologically
Important Synthetic Organoselenium Compounds . Chem. Rev. 
2001 , 101 , 2125 –2180 . 10.1021/cr000426w .11710243  b Nogueira C. W. ; Zeni G. ; Rocha J. B. T. 
Organoselenium
and Organotellurium Compounds: Toxicology and Pharmacology . Chem. Rev. 
2004 , 104 , 6255 –6286 . 10.1021/cr0406559 .15584701  c Woods J. A. ; Hadfield J. A. ; McGown A. T. ; Fox B. W. 
Bioactivity
and molecular modelling of diphenylsulfides and diphenylselenides . Bioorg. Med. Chem. 
1993 , 1 , 333 –340 . 10.1016/s0968-0896(00)82139-2 .8081863  d Engman L. ; Stern D. ; Frisell H. ; Vessman K. ; Berglund M. ; Ek B. ; Andersson C.-M. 
Synthesis,
antioxidant properties, biological activity and molecular modelling
of a series of chalcogen analogues of the 5-lipoxygenase inhibitor
DuP 654 . Bioorg. Med. Chem. 
1995 , 3 , 1255 –1262 . 10.1016/0968-0896(95)00111-s .8564418 e Bernardon J.-M. ; Diaz P.   PCT Int. Appl. WO 1999065872 A1 , 1999 . f Millois C. ; Diaz P. 
Solution-Phase Synthesis
of Diaryl Selenides Using Polymer-Supported Borohydride . Org. Lett. 
2000 , 2 , 1705 –1708 . 10.1021/ol0058184 .10880206 
a Ando T. ; Kwon T. S. ; Kitagawa A. ; Tanemura T. ; Kondo S. ; Kunisada H. ; Yuki Y. 
Synthesis
and free
radical polymerization of p-methylseleno- and p-phenylselenostyrenes . Macromol.
Chem. Phys. 
1996 , 197 , 2803 –2810 . 10.1002/macp.1996.021970918 . b Khanna P. K. ; Das B. K. 
Novel synthesis of silver selenide
nano-powder from silver nitrate and organo-selenium compound . Mater. Lett. 
2004 , 58 , 1030 –1034 . 10.1016/j.matlet.2003.08.007 . c Frizon T. E. ; Rampon D. S. ; Gallardo H. ; Merlo A. A. ; Schneider P. H. ; Rodrigues O. E. D. ; Braga A. L. 
Selenides and diselenides
containing oxadiazoles: a new class of functionalised materials . Liq. Cryst. 
2012 , 39 , 769 –777 . 10.1080/02678292.2012.680505 . d Wirth T. 
Chiral selenium compounds in organic synthesis . Tetrahedron 
1999 , 55 , 1 –28 . 10.1016/s0040-4020(98)00946-6 .
Okamoto Y.  The Chemistry of Organic
Selenium and Tellurium Compounds ; Patai S. , Rappoport Z.  , Eds.; Wiley : Chichester, U.K. , 1986 .
a Da Re P. ; Primofiore G. P. ; Bertelli A. 
.beta.-Adrenergic blocking
agents of the chromone and xanthone groups. II. Propanolol type derivatives . J. Med. Chem. 
1972 , 15 , 868 –869 . 10.1021/jm00278a029 .4402954  b Shetty H. U. ; Nelson W. L. 
Chemical and stereochemical aspects
of propranolol metabolism. Diastereomeric 1-(1-hydroxy-2-propylamino)-3-(1-naphthoxy)-2-propanols
produced by rat liver microsomal .omega.-hydroxylation . J. Med. Chem. 
1986 , 29 , 2004 –2008 . 10.1021/jm00160a034 .3761318  c Hellberg M.
R. ; Namil A. ; Delgado P. ; David K. C. ; Kessler T. L. ; Graff G. ; Haggard K. S. ; Nixon J. C. 
Novel Esters and Amides of Nonsteroidal
Antiinflammatory Carboxylic Acids as Antioxidants and Antiproliferative
Agents . J. Med. Chem. 
1999 , 42 , 267 –276 . 10.1021/jm980430o .9925732  d Rautio J. ; Nevalainen T. ; Taipale H. ; Vepsäläinen J. ; Gynther J. ; Laine K. ; Järvinen T. 
Synthesis
and in Vitro Evaluation of Novel Morpholinyl- and Methylpiperazinylacyloxyalkyl
Prodrugs of 2-(6-Methoxy-2-naphthyl)propionic Acid (Naproxen) for
Topical Drug Delivery . J. Med. Chem. 
2000 , 43 , 1489 –1494 . 10.1021/jm991149s .10780905  e Sarigol D. ; Uzgoren-Baran A. ; Tel B. C. ; Somuncuoglu E. I. ; Kazkayasi I. ; Ozadali-Sari K. ; Unsal-Tan O. ; Okay G. ; Ertan M. ; Tozkoparan B. 
Novel thiazolo[3,2-b]-1,2,4-triazoles derived from naproxen with analgesic/anti-inflammatory
properties: Synthesis, biological evaluation and molecular modeling
studies . Bioorg. Med. Chem. 
2015 , 23 , 2518 –2528 . 10.1016/j.bmc.2015.03.049 .25868745  f Shan N. K. ; Shah N. M. ; Patel M. P. ; Patel R. G. 
Synthesis of 2-amino-4H-chromene derivatives under microwave irradiation and their
antimicrobial activity . J. Chem. Sci. 
2013 , 125 , 525 –530 . 10.1007/s12039-013-0421-y . g Hallock Y. F. ; Manfredi K. P. ; Blunt J. W. ; Cardellina J. H. ; Schaeffer M. ; Gulden K.-P. ; Bringmann G. ; Lee A. Y. ; Clardy J. ; François G. ; Boyd M. R. 
Korupensamines A-D, Novel Antimalarial Alkaloids from
Ancistrocladus korupensis . J. Org. Chem. 
1994 , 59 , 6349 –6355 . 10.1021/jo00100a042 . h Araújo M. J. ; Bom J. ; Capela R. ; Casimiro C. ; Chambel P. ; Gomes P. ; Iley J. ; Lopes F. ; Morais J. ; Moreira R. ; de Oliveira E. ; do Rosário V. ; Vale N. 
Imidazolidin-4-one
Derivatives of Primaquine as Novel Transmission-Blocking Antimalarials . J. Med. Chem. 
2005 , 48 , 888 –892 . 10.1021/jm0494624 .15689174  i Salas P. F. ; Herrmann C. ; Orvig C. 
Metalloantimalarials . Chem. Rev. 
2013 , 113 , 3450 –3492 . 10.1021/cr3001252 .23425067  j Boyd M. R. ; Hallock Y. F. ; Cardellina J. H. ; Manfredi K. P. ; Blunt J. W. ; McMahon J. B. ; Buckheit R. W. ; Bringmann G. ; Schäffer M. ; Cragg G. M. ; Thomas D. W. ; Jato J. G. 
Anti-HIV Michellamines from Ancistrocladus korupensis . J. Med. Chem. 
1994 , 37 , 1740 –1745 . 10.1021/jm00038a003 .8021914 
a Nishiyama Y. ; Tokunaga K. ; Sonoda N. 
New Synthetic Method
of Diorganyl Selenides: Palladium-Catalyzed Reaction of PhSeSnBu3with
Aryl and Alkyl Halides . Org. Lett. 
1999 , 1 , 1725 –1727 . 10.1021/ol990233z . b Itoh T. ; Mase T. 
A General Palladium-Catalyzed Coupling of Aryl Bromides/Triflates
and Thiols . Org. Lett. 
2004 , 6 , 4587 –4590 . 10.1021/ol047996t .15548082  c Cristau H. J. ; Chabaud B. ; Chêne A. ; Christol H. 
Synthesis of Diaryl
Sulfides by Nickel(II)-Catalyzed Arylation of Arenethiolates . Synthesis 
1981 , 892 –894 . 10.1055/s-1981-29636 . d Takagi K. 
Nickel(0)-catalyzed Synthesis of Diaryl Sulfides from
Aryl Halides and Aromatic Thiols . Chem. Lett. 
1987 , 16 , 2221 –2224 . 10.1246/cl.1987.2221 . e Suzuki H. ; Abe H. ; Osuka A. 
Copper(I) iodide-Facilitated Nucleophilic Substitutions
Of Nonactivated Aryl Iodides With Areneselenolates . Chem. Lett. 
1981 , 10 , 151 –152 . 10.1246/cl.1981.151 . f Kwong F. Y. ; Buchwald S. L. 
A General, Efficient, and Inexpensive
Catalyst System for the Coupling of Aryl Iodides and Thiols . Org. Lett. 
2002 , 4 , 3517 –3520 . 10.1021/ol0266673 .12323058  g Gujadhur R. K. ; Venkataraman D. 
A general method for the formation
of diaryl selenides using copper(I) catalysts . Tetrahedron Lett. 
2003 , 44 , 81 –84 . 10.1016/s0040-4039(02)02480-2 . h Wang M. ; Ren K. ; Wang L. 
Iron-Catalyzed Ligand-Free
Carbon-Selenium (or Tellurium) Coupling of Arylboronic Acids with
Diselenides and Ditellurides . Adv. Synth. Catal. 
2009 , 351 , 1586 –1594 . 10.1002/adsc.200900095 . i Correa A. ; Carril M. ; Bolm C. 
Iron-Catalyzed S-Arylation of Thiols
with Aryl Iodides . Angew. Chem. 
2008 , 120 , 2922 –2925 . 10.1002/ange.200705668 . j Beletskaya I. P. ; Sigeev A. S. ; Peregudov A. S. ; Petrovskii P. V. 
Preparation
of unsymmetrical diaryl selenides in nucleophilic substitution reactions
with activated aryl fluorides . Mendeleev Commun. 
2000 , 10 , 213 –214 . 10.1070/mc2000v010n06abeh001363 . k Saba S. ; Rafique J. ; Franco M. S. ; Schneider A. R. ; Espíndola L. ; Silva D. O. ; Braga A. L. 
Rose Bengal catalysed
photo-induced selenylation of indoles, imidazoles and arenes: a metal
free approach . Org. Biomol. Chem. 
2018 , 16 , 880 –885 . 10.1039/c7ob03177g .29340417 
a Iwasaki M. ; Tsuchiya Y. ; Nakajima K. ; Nishihara Y. 
Chelate-Assisted
Direct Selenation of Aryl C-H Bonds with Diselenides Catalyzed by
Palladium . Org. Lett. 
2014 , 16 , 4920 –4923 . 10.1021/ol502439m .25207677  b Mandal A. ; Sahoo H. ; Baidya M. 
Copper-Catalyzed 8-Aminoquinoline-Directed
Selenylation of Arene and Heteroarene C-H Bonds . Org. Lett. 
2016 , 18 , 3202 –3205 . and reference cited therein 10.1021/acs.orglett.6b01420 .27309343 
a Chatterjee T. ; Ranu B. C. 
Solvent-Controlled
Halo-Selective
Selenylation of Aryl Halides Catalyzed by Cu(II) Supported on Al2O3. A General Protocol for the Synthesis of Unsymmetrical
Organo Mono- and Bis-Selenides . J. Org. Chem. 
2013 , 78 , 7145 –7153 . and reference cited therein 10.1021/jo401062k .23786642  b Mukherjee N. ; Chatterjee T. ; Ranu B. C. 
Reaction under Ball-Milling: Solvent-,
Ligand-, and Metal-Free Synthesis of Unsymmetrical Diaryl Chalcogenides . J. Org. Chem. 
2013 , 78 , 11110 –11114 . 10.1021/jo402071b .24116379  c Kundu D. ; Ahammed S. ; Ranu B. C. 
Visible
Light Photocatalyzed Direct Conversion of Aryl-/Heteroarylamines to
Selenides at Room Temperature . Org. Lett. 
2014 , 16 , 1814 –1817 . 10.1021/ol500567t .24621272  d Maity P. ; Ahammed S. ; Manna R. N. ; Ranu B. C. 
Calcium mediated
C-F bond substitution in fluoroarenes towards C-chalcogen bond formation . Org. Chem. Front. 
2017 , 4 , 69 –76 . 10.1039/c6qo00515b .
Silva L. T. ; Azeredo J. B. ; Saba S. ; Rafique J. ; Bortoluzzi A. J. ; Braga A. L. 
Solvent and Metal-Free
Chalcogenation of Bicyclic Arenes
Using I2/DMSO as Non-Metallic Catalytic System . Eur. J. Org. Chem. 
2017 , 4740 –4748 . 10.1002/ejoc.201700744 .
a Maity P. ; Paroi B. ; Ranu B. C. 
Transition-Metal-Free
Iodine Catalyzed Selenocayanation of Styrenyl Bromides and an Easy
Access to Benzoselenophenes via Intermediacy of Styrenyl Selenocyanate . Org. Lett. 
2017 , 19 , 5748 –5751 . 10.1021/acs.orglett.7b02571 .29072469  b Singh D. ; Deobald A. M. ; Camargo L. R. S. ; Tabarelli G. ; Rodrigues O. E. D. ; Braga A. L. 
An Efficient One-Pot Synthesis of
Symmetrical Diselenides or Ditellurides from Halides with CuO Nanopowder/Se0or
Te0/Base . Org. Lett. 
2010 , 12 , 3288 –3291 . 10.1021/ol100558b .20586442

